WMA gains funding to support TB training course

Pharma company Eli Lilly has increased an existing partnership with the World Medical Association (WMA) by granting c. 646,505 euros to expand online training courses for physicians on multi-drug resistant tuberculosis (MDR-TB), which they have been developed over the past year.

The course aims to help physicians to more effectively diagnose, prevent and treat MDR-TB. Clinical guidelines were developed and harmonised with evidence-based material sourced from the WHO, International Council of Nurses and the International Hospital Federation.
The course was tested among physicians in South Africa.
The German Medical Association gave managerial support for the conception of the project, and the Norwegian Medical Association adapted the material to a web-based format and will provide CME credits to course participants.
The new four-year joint partnership agreement was signed in Geneva in May by Jacques Tapiero, president of Lilly’s intercontinental operations and WMA president Dr Jon Snaedal. ‘Given adequate healthcare infrastructure and adherence to proper medication regimens, MDR-TB is not only treatable, but indeed curable,’ said Jacques Tapiero. ‘This online training course is an important addition to the already existing tools and activities of a larger partnership of 16 public and private organisations worldwide dedicated to fighting MDR-TB.’
Dr Snaedal added that the course will now be made more interactive, with more case studies and a progressive learning pattern. ‘A TB refresher course is important to get physicians back on track regarding the basic knowledge of standard TB,’ he explained.
Currently in English, the online course is being translated into Spanish, French, Chinese and Russian. It will also be published in handbook and CD form.
FREE course access: www.WMA.net/
Or via the Norwegian Medical Association: http://lupin-nma.net/


Read all latest stories

Related articles


Article •

ECCO 15 and 34th ESMO Multidisciplinary Congress unites European Oncology

The first joint congress ECCO 15 - ESMO 34 of the European CanCer Organisation (ECCO) and the European Society for Medical Oncology (ESMO) is taking place this week in Berlin. It is the only…


Article •

Colorectal cancers

Incidence data from cancer registries have drawn the attention to colorectal cancer. It is one of the most common cancers in developed countries. In 2006, the estimated number of new cases in the…

Article •


Researchers around the globe are studying whether a genomic test, developed with micro-array technology, is superior to traditional methods in assessing aggressive breast cancer, and therefore could…

Subscribe to Newsletter